Therapeutics IV Tutoring May 6, 2016 Lisa Hayes

Slides:



Advertisements
Similar presentations
Addressing Obesity and Exercise in Primary Care GSP 4 th Year Elective 2010.
Advertisements

Is it Right for You?. Also known as: Bariatric surgery, laparoscopic gastric bypass or Roux-en-Y gastric bypass Gastric bypass is surgery that helps you.
In-Patient Management of Hyperglycemia Rey Vivo, MD Assistant Professor of Medicine Texas Tech University Health Sciences Center.
Diabetes and Hypothyroidism
State-by-State Treatment of Obesity Interventions Christine Ferguson Professor George Washington University School of Public Health and Health Services.
Assessment of Overweight and Obesity and the Need for Weight Loss Dr. David L. Gee FCSN/PE 446 Nutrition, Weight Control & Exercise.
10 Points to Remember for the Management of Overweight and Obesity in Adults Management of Overweight and Obesity in Adults Summary Prepared by Elizabeth.
Pathophsiology of Metabolism. Obesity What Is Obesity? Obesity means having too much body fat.
11 Questions About Metabolic Syndrome Metabolic syndrome is a group of risk factors -- unhealthy cholesterol levels, high blood pressure, high blood sugar,
Effect of Obesity on Kidney Transplantation Reference: Potluri K, Hou S. Obesity in kidney transplant recipients and candidates. Am J Kidney Dis. 2010;56:143–156.
Obesity. What is Obesity Obesity is an excess proportion of total body fat. A person is considered obese when his or her weight is 20% or more above normal.
Characteristics and Treatment of Common Endocrine Disorders
Case Studies Advanced Heart Failure and the Role of Mechanical Circulatory Support Megan Shifrin, RN, MSN, ACNP-BC Vanderbilt University.
Obesity Treatment in Special Populations
Carly Pabon NTR 573 Spring  The different types of bariatric surgery, their prevalence, and effectiveness.  Qualifications for bariatric surgery.
COMMON LIFESTYLE DISEASES
Beyond Dieting: New Weight Loss Medications & Treatments on the Horizon Daniel Bessesen, MD.
Evolving Treatment Strategies: The Complexity of Energy Homeostasis Artificial sweetners lead to weight gain?
Patient selection and choosing the optional procedure in bariatric surgery A.R khalaj M.D Minimal Invasive Surgery Research Center university of Iran.
HEALTHY EATING And LIVING Kenneth E. Nixon MD. Problem Overweight and Obesity 97 million adults are overweight or obese Medical Problems Associated with.
Ambulatory Care Pharmacy
METABOLIC SYNDROME Dr Gerhard Coetzer. Complaint Thirsty all the time Urinating more than usual Blurred vision Tiredness.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 82 Drugs for Weight Loss.
Management of Obesity and Dyslipidemia Presented by : Faisal Hassan Hussain.
Michigan Model Nutrition Lesson 3 What is the formula for weight management?
The American Academy of Orthopaedic Surgeons GET UP, GET OUT, GET MOVING!
OBesity Project Pregnancy.
OBESITY Babes-Bolyai University, Cluj-Napoca Faculty of Chemistry and Chemical Engineering Contra Gabriela Dobie Cristina Macec Rucsandra.
OBESITY Fighting the Battle of the Bulge. Overview  Energy  Definition of obesity  Etiology/pathogenesis  Obesity/health hazards  Evaluation of the.
CARDIOVASCULAR CARE of the OUTPATIENT Diane M. Enzweiler, MSN, ANP-BC St. Elizabeth Physicians: Heart and Vascular.
 What is different from inpatient and outpatient counseling?  Case Studies.
OBESITY Characterized by having excess adipose tissue BMI = ( Weight in Pounds / ( Height in inches x Height in inches ) ) x 703 Over 1/3 Americans are.
Hypertension (High Blood Pressure)
Saxenda (Liraglutide) SAMUEL GYAWU-AMOATENG. Indication & Approval  Saxenda, is FDA approved as a treatment option for chronic weight management in addition.
BELL WORK What do you think are some factors in the rise of obesity?
There are many reasons for being underweight, these are some of them: - High metabolism - Skipping meals - eating on the run - illness - injury - active.
Chapter 15 Adolescent Nutrition: Conditions and Interventions
Obesity in the Pediatric Transplant Patient a growing problem – despite the best of intentions Elizabeth Gerndt-Spaith, RN, BSN, CCTC 10/8/2011.
Moving Toward a Healthy Weight Lesson 2. Obesity is defined as having too much body fat.
Dyslipidemia.  Dyslipidemia is elevation of plasma cholesterol, triglycerides (TGs), or both, or a low high- density lipoprotein level that contributes.
Hunger Vs. Appetite Hunger Appetite
Risk of hypertension (HTN) and non-drug management Aliakbar Tavassoli.
Medicine used in the Treatment of Obesity
05 Pharmaceutical Care Drug Related Problems Prepared by Refaa AlAjmi Identify the drug related problem in the following case.
The FATZO mouse as a Translational Model for the Development of Drugs for Obesity, Metabolic Syndrome and Diabetes. PreClinOmics, Inc. 1.
Body Composition Analysis Form
Obesity in the UK Warda Salim Aryan Ala’Aldeen. Definition Obesity is when a persons body weight is 20% beyond their ideal weight It is a condition in.
Copyright © 2016 McGraw-Hill Education. All rights reserved. No reproduction or distribution without the prior written consent of McGraw-Hill Education.
Obesity in the UK By Siddharth Reddiar and Mitul Patel.
Obesity By: Dr. Wael Thanoon C.A.B.M. College of medicine,Mosul University.
Lesson 29  What are the negative side effects of having an eating disorder?  Who should you consult to determine your desirable weight?  What is the.
Pharmacokinetics: Digoxin Allie Punke
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults Scott W. Rypkema, M.D.
ALLIE PUNKE PHARMACOKINETICS: ANTIEPILEPTIC DRUGS.
Special Situations In The Management Of In-Patient Hyperglycemia
Bariatric Surgery for T2DM The STAMPEDE Trial. A.R. BMI 36.5 T2DM diagnosed age 24 On Metformin, glyburide  insulin Parents with T2DM, father on dialysis.
By: Lori Sanderson, LCSW, MPH, PhD Date: April 26, 2016.
Keeping A Healthy Weight
Maintaining a Healthful Weight
OBESITY WORKSHOP.
Melanie Jaeger T4 Tutoring.
Recurrent falls in an older woman with diabetes
Drugs for Weight Loss 1.
Effect of Metabolic Surgery on diabetes and hypertension
Cardiovascular System
Weight Regulation: Discovery Timeline
Obesity.
Obesity Eppie Habashi.
Medical Management of Obesity
Obesity By Aiden, Naier ,MT.
Presentation transcript:

Therapeutics IV Tutoring May 6, 2016 Lisa Hayes

Topics Heart Transplant Childhood Obesity Adult Obesity

Heart Transplant Disclaimer – We were not tested on this last year!

What is the most common reason for a heart transplant? A – congenital dz B – cardiomyopathy C - CAD D – valvular dz

Which of the following is an appropriate reason to recommend a heart transplant/VAD? A – ejection fraction of 18% B – major limitation to ADL + peak VO2 of 8mL/kg/min C – recurrent ischemia not able to use CABG or PCI D – cardiogenic shock responding to oral med

Which of the following is NOT a contraindication to transplant? A – malignant brain tumor, removed 4 years ago B – MRSA bacteremia with WBC 17K C – severe diabetes with kidney damage (SCR 1.4) D – BMI 23

Which type of patient may require a VAD more often than others? A – HLA mismatch B – “A” blood types C – transplant decision made easily

Which of the following can be a significant complication of a VAD? A – bleeding B – thromboembolism C – infection D – all of the above

I did not cover transplant meds. Please remember to review these. Interactions with tacrolimus/sirolimus – Remember dilt + tacrolimus Review risk factors for rejection

Childhood obesity

Which of the following is not associated with metabolic syndrome? A – hypercoagulability B – normotension C – dyslipidemia D – insulin resistance

Which of the following statements about sleep and childhood obesity is true? A – sleep duration is not associated with increased risk of obesity in ages 0-5y B – short sleep duration is associated with increased risk of becoming obese in years 5-13 C – daytime naps help decrease the risk of obesity D – decreased sleep duration is tied to increased food intake

Know what a microbiome is.

In which patient would Orlistat be appropriate? A – 10 year old female with BMI 26 B – 9 year old male with BMI 25 C – 13 year old male with BMI 27 D – 11 year old female with BMI 28

Which of the following is most appropriate regarding Metformin for obesity in pediatrics? A – Metformin is an approved treatment for obesity in pediatrics B – Metformin works better in Caucasian patients C – Metformin works better if a higher BMI is present at baseline D – Metformin should be started at 1000mg BID

Adult Obesity

Calculate and BMI for BH and quantify his obesity. 5’7” 317# A – BMI 43 - obese B – BMI 50 – extreme obesity C – BMI 48 – extreme obesity D – BMI 42 – morbidly obese

Which of the following drugs is not known to contribute to weight gain? A – Levemir B – Valproate C – Lo Estrin D - HCTZ

TR is a 5’4” female who weighs 170 pounds. PMH: migraines, HTN, DM. Which recommendation is most appropriate? A – Recommend 5-10% body weight loss in 6 months B – Recommend no weight loss but no weight gain C – Recommend 3% body weight loss in 3 months D – recommend 5-10% body weight loss in 3 months

28 y/o RT presents to your clinic requesting help with losing weight. She has a BMI of 33. PMH HTN, hypothyroid, migraine, seizure disorder. Which of the following would be most appropriate for short term therapy? A – phentermine B – qysmia C – belviq D – none of the above

WH has been on Qysmia at 7.5mg/46mg dose for 12 weeks. Patient has been compliant with medication + diet. Weight loss is 12 pounds. Starting weight 227 pounds. What should you recommend? A - titrate up to 15mg/92mg for additional 6 weeks B – titrate up to 15mg/92mg for additional 12 weeks C – discontinue therapy D – continue 7.5mg/46mg dose

EW has been on Belviq for 13 weeks. Initial weight 223 pounds. Weight loss 7 pounds. She says her heart is racing all the time. What do you recommend? A – continue for additional 12 weeks B – address adherence C – discontinue D – get full medication list

TR is a patient who is 31 years old and has a BMI of 32. She is considering becoming pregnant in the next 3- 6months. Which of the following could you recommend to her for weight loss? A – Qysmia B – Phentermine C – Belviq D – Orlistat

Which of the following does not show improvement with weight loss? A – sleep apnea B – COPD C – HTN D – cancer

What is an appropriate counseling point for Orlistat? A – there are no drug interactions for this medication because it works in the gut B – Use only for 3 months at a time C – Use caution when eating high fat foods, this is not recommended D – This drug has no other names so don’t worry about confusing it with an OTC product

True or False: Fat can function as an endocrine organ. A – true B – false

Which of the following is not a recommendation for a patient post bariatric surgery? A – avoid ER tablets B – split pills larger than the size of a thumbnail to avoid blocking the band C – recommend using calcium citrate over calcium carbonate D – recommend appropriate vitamin supplementation (ADEK, folic acid, etc)

What is the difference between Saxenda and Victoza? A – contraindications B – starting dose C – ending dose D – drug component

Which of the following should not be used if the patient has an eating disorder due to the component medication? A – phentermine B – Contrave C – Belviq D – Orlistat

Thanks!!! Please me with questions. Good Luck! Happy P3 status!